| Literature DB >> 30518328 |
Bradley C Johnston1,2, Pablo Alonso-Coello3,4,5, Malgorzata M Bala6, Dena Zeraatkar3, Montserrat Rabassa4, Claudia Valli4, Catherine Marshall7, Regina El Dib8,9, Robin W M Vernooij8,10, Per O Vandvik11,12, Gordon H Guyatt3,13.
Abstract
BACKGROUND: Recent systematic reviews and editorials suggest that many organizations that produce nutritional guideline recommendations do not adhere to internationally recognized standards set forth by the Institute of Medicine (IoM), Guidelines International Network (GIN), Appraisal of Guidelines Research and Evaluation (AGREE), and Grading Recommendations, Assessment, Development and Evaluation (GRADE).Entities:
Keywords: Evidence-based; Guidelines; Nutrition; Patient engagement; Recommendations
Mesh:
Year: 2018 PMID: 30518328 PMCID: PMC6280455 DOI: 10.1186/s12874-018-0621-8
Source DB: PubMed Journal: BMC Med Res Methodol ISSN: 1471-2288 Impact factor: 4.615
Institute of Medicine standards for trustworthy guidelines (2011)
| Transparency: details on guideline development and funding are explicit and publicly accessible | |
| Management of conflicts of interest: prior to finalizing guideline, panelists being considered for membership should declare all interests and activities potentially resulting in conflicts, and all conflicts should be minimized | |
| Guideline group composition is multidisciplinary with methodological expertise and including patient and community involvement | |
| Use of systematic reviews for guideline questions | |
| Establishing evidence foundations for and rating strength of recommendations | |
| Clear articulation of recommendations | |
| External review by a full spectrum of stakeholders (e.g. scientific and clinical experts, patients and community representatives) |
Certainty of evidence
|
|
|
|---|---|
|
| We are very confident that the true effect lies close to that of the estimate of the effect |
|
| We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different |
|
| Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect |
|
| We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect |
Although certainty of evidence is a continuum; GRADE’s discrete categorisation involves some degree of arbitrariness. Nevertheless, advantages of simplicity, transparency, and vividness outweigh these limitations
Implications of strong and weak recommendations for different end-users
|
|
|
|
|---|---|---|
|
| Most individuals in this situation would want the recommended course of action and only a small proportion would not. | The majority of individuals in this situation would want the suggested course of action, but many would not. |
|
| Most individuals should receive the recommended course of action. Adherence to this recommendation according to the guideline could be used as a quality criterion or performance indicator. Formal decision aids are not likely to be needed to help individuals make decisions consistent with their values and preferences. | Recognize that different choices will be appropriate for different patients, and that you must help each patient arrive at a management decision consistent with her or his values and preferences. Decision aids may well be useful helping individuals making decisions consistent with their values and preferences. Clinicians should expect to spend more time with patients when working towards a decision. |
|
| The recommendation can be used to develop policy (e.g. tax on products high in sugar or salt) | Policy-making will require substantial debates and involvement of many stakeholders. Policies are also more likely to vary between regions. Performance indicators would have to focus on the fact that adequate deliberation about the management options has taken place. |
Evidence to decision framework
| Judgement | Research evidence | Additional considerations | |
|---|---|---|---|
| PROBLEM | Is the problem a priority? | ||
| DESIRABLE EFFECTS | How substantial are the desirable anticipated effects? | ||
| UNDESIRABLE EFFECTS | How substantial are the undesirable anticipated effects? | ||
| CERTAINTY OF EVIDENCE | What is the overall certainty of the evidence of effects? | ||
| VALUES | Is there important uncertainty about or variability in how much people value the main outcomes? | ||
| BALANCE OF EFFECTS | Does the balance between desirable and undesirable effects favor the intervention or the comparison? | ||
| RESOURCES REQUIRED | How large are the resource requirements (costs)? | ||
| RESOURCES REQUIRED | What is the certainty of the evidence of resource requirements (costs)? | ||
| COST EFFECTIVENESS | Does the cost-effectiveness of the intervention favor the intervention or the comparison? | ||
| EQUITY | What would be the impact on health equity? | ||
| ACCEPTABILITY | Is the intervention acceptable to key stakeholders? | ||
| FEASIBILITY | Is the intervention feasible to implement? |